NAPPSA 20th Annual Scientific Conference — 2026 Program
September 17–20, 2026 · Hyatt Regency Aurora-Denver Conference Center, Aurora, CO
Thursday, September 17, 2026
| Time | Session | Room |
|---|---|---|
| 10:00 AM – 5:00 PM | RegistrationRegistration | Aurora Foyer |
| 11:45 AM – 12:30 PM | LunchMeal | TBD |
| 12:30 PM – 12:45 PM | Welcome AddressCeremony Kunle Tometi, PharmD, FNAPPSA, President, NAPPSA | Aurora I/II |
| 12:45 PM – 1:20 PM | #101 – Charles Okechukwu EsimoneCEPlenary Session #100A: Bridging Pharmacy Education and Practice Innovation through Collaboration (Part 1) Charles Okechukwu Esimone, FAS, FPSN, FNAPharm - Prochancellor, European University of Nigeria | Aurora I/II |
| 1:20 PM – 1:50 PM | #102 – Azuka C. OparahCEPlenary Session #100A: Bridging Pharmacy Education and Practice Innovation through Collaboration (Part 1) Prof. Azuka C. Oparah - Department of Clinical Pharmacy, University of Benin | Aurora I/II |
| 1:50 PM – 2:20 PM | #103 – Samuel O. AdekolaCEPlenary Session #100A: Bridging Pharmacy Education and Practice Innovation through Collaboration (Part 1) Samuel O. Adekola, FPSN, FNAPharm - Senior Consultant, Ondo State Government | Aurora I/II |
| 2:20 PM – 3:00 PM | Moderated Discussion & Q&A (Session #100A)Discussion Session #100A: Bridging Pharmacy Education and Practice Innovation through Collaboration (Part 1) Panelists: Esimone, Oparah, Adekola • Moderator: Juliet Obi, PhD (Eli Lilly and Company) | Aurora I/II |
| 3:00 PM – 3:30 PM | BreakBreak | TBD |
| 3:30 PM – 4:00 PM | #104 – Nonye OnyewuenyiCEPlenary Session #100B: Bridging Pharmacy Education and Practice Innovation through Collaboration (Part 2) Nonye Onyewuenyi, PhD - CEO & Chief Scientific Officer, Noniks Analytics | Aurora I/II |
| 4:00 PM – 5:30 PM | Panel Discussion on Patient Safety and Shared Risk (Session #100B)CEDiscussion Session #100B: Bridging Pharmacy Education and Practice Innovation through Collaboration (Part 2) Panelists: Prof. Cyril Usifoh (University of Benin); Pharm. Ibrahim Babashehu Ahmed (Pharmacy Council of Nigeria); Emilia Iwu, PhD, RN, APNC, FWACN, FAAN • Moderator: Theresa Ofili, PharmD, MPH, RN (Texas A&M School of Pharmacy) | Aurora I/II |
| 6:30 PM | ReceptionSocial | TBD (moves to Presidential Suite at 7:30 PM) |
Friday, September 18, 2026
| Time | Session | Room |
|---|---|---|
| 7:00 AM – 5:00 PM | RegistrationRegistration | Aurora Foyer |
| 7:30 AM – 9:00 AM | BreakfastMeal | TBD |
| 9:00 AM – 9:30 AM | Opening CeremonyCeremony Kunle Tometi, PharmD, FNAPPSA, President, NAPPSA | TBD |
| 9:30 AM – 10:15 AM | #201 – Bankole Aminu EzebuiloCEPlenary Session #200: Globalizing Innovations in Healthcare: Bridging Science, Access, and Impact Bankole Aminu Ezebuilo, FPSN, MD - CEO, Kayhelt Pharma; Industrial Pharmacist Chairman of Nigeria | Aurora I/II |
| 10:15 AM – 11:00 AM | #202 – J. Valentine OkeluCEPlenary Session #200: Globalizing Innovations in Healthcare: Bridging Science, Access, and Impact J. Valentine Okelu, FPSN - Managing Director/CEO, Neimeth International Pharmaceuticals PLC | Aurora I/II |
| 11:00 AM – 11:30 AM | #203 – Ahmad Nuhu BamalliCEPlenary Session #200: Globalizing Innovations in Healthcare: Bridging Science, Access, and Impact His Highness Ambassador Ahmad Nuhu Bamalli, CFR, LLD - the Emir of Zazzau; Chairman, Kaduna State Council of Chiefs | Aurora I/II |
| 11:30 AM – 12:00 PM | Moderated Discussion & Q&A (Session #200)Discussion Session #200: Globalizing Innovations in Healthcare: Bridging Science, Access, and Impact Panelists: Ezebuilo, Okelu, Bamalli • Moderator: Olu Aloba, PhD, RPh (Premier Research) | Aurora I/II |
| 12:00 PM – 3:00 PM | LunchMeal | TBD |
| 12:00 PM – 3:00 PM | ExhibitionExhibition | Conference Room VI |
| 3:00 PM – 3:30 PM | #301 – Olu AlobaCEPlenary Session #300: Drug Development and Manufacturing for Access: Innovations That Reduce Cost, Complexity, and Risk Olu Aloba, PhD, RPh - Vice President, CMC Services, Premier Research | Aurora I/II |
| 3:30 PM – 4:00 PM | #302 – Uzoma EzeokeCEPlenary Session #300: Drug Development and Manufacturing for Access: Innovations That Reduce Cost, Complexity, and Risk Uzoma Ezeoke, FPSN - Executive Director, Emzor Pharmaceutical Industries Limited | Aurora I/II |
| 4:00 PM – 4:30 PM | #303 – Joseph FortunakCEPlenary Session #300: Drug Development and Manufacturing for Access: Innovations That Reduce Cost, Complexity, and Risk Joseph Fortunak, PhD - Howard University | Aurora I/II |
| 4:30 PM – 5:00 PM | #304 – Jude NwokikeCEPlenary Session #300: Drug Development and Manufacturing for Access: Innovations That Reduce Cost, Complexity, and Risk Jude Nwokike, PhD, MSc, MPH, BPharm - Vice President, USP Resiliency Center | Aurora I/II |
| 5:00 PM – 5:30 PM | Moderated Discussion & Q&A (Session #300)Discussion Session #300: Drug Development and Manufacturing for Access: Innovations That Reduce Cost, Complexity, and Risk Panelists: Aloba, Ezeoke, Fortunak, Nwokike • Moderator: Okezie Aruoma, PhD, DSc, MBA (Global PharmHealth Investors Inc.) | Aurora I/II |
| 7:00 PM | Welcome Reception & NetworkingSocial | TBD |
Saturday, September 19, 2026
| Time | Session | Room |
|---|---|---|
| 6:00 AM – 9:00 AM | NAPPSA 5K RunSocial | Details and assembly point announced onsite |
| 7:00 AM – 5:00 PM | RegistrationRegistration | Aurora Foyer |
| 9:00 AM – 10:00 AM | Late BreakfastMeal | TBD |
| 10:00 AM – 11:00 AM | #501 – YP Session Panel DiscussionCEBreakout Parallel Session B - Session #500: YP Session - Building a Borderless Career in Pharmacy and Pharmaceutical Sciences Panelists: Chinyere Onyebuchi, PhD, PMP (Takeda Pharmaceuticals); Toluleke Famuyiwa, PhD (NIH); Nedra Chijioke, PharmD, RPh (Takeda Pharmaceuticals); Precious Okeke, PharmD, RPh, MSc (Texas A&M College of Pharmacy) • Moderator: Juliet Obi, PhD (Eli Lilly and Company) | Conference Room IV |
| 10:00 AM – 10:30 AM | #401 – Akin AkinseyeCEBreakout Parallel Session A - Session #400: Pharmacy Business Innovations: Models, Policy, and Technology for Access and Impact Akin Akinseye, RPh, PSM, CSPO - Creative Director, SlimionRx | Aurora Ballroom |
| 10:30 AM – 11:00 AM | #402 – Chidebelu UfodikeCEBreakout Parallel Session A - Session #400: Pharmacy Business Innovations: Models, Policy, and Technology for Access and Impact Chidebelu Ufodike, PharmD - Chief Operating Officer, Carnavio Inc | Aurora Ballroom |
| 11:00 AM – 11:40 AM | Session #600: Keynote PresentationCEKeynote Session #600: Keynote Oluyinka Olutoye, MD, PhD - Surgeon-in-Chief, Nationwide Children's Hospital | Aurora Ballroom |
| 11:40 AM – 12:00 PM | Panel Discussion with Keynote SpeakerDiscussion Session #600: Keynote Panelist: Oluyinka Olutoye, MD, PhD • Moderator: Gerald Muforo, PharmD (Walmart Pharmacy, Tampa, FL) | Aurora Ballroom |
| 12:00 PM – 2:00 PM | LunchMeal | TBD |
| 12:00 PM – 2:00 PM | Poster ViewingPoster | Conference Room VI |
| 12:00 PM – 2:00 PM | ExhibitionExhibition | Conference Room VI |
| 2:00 PM – 2:30 PM | #701 – Todd RaehtzCEBreakout Session #700: Pharmacy Practice - Transforming Health-System Pharmacy Practice: Access and Impact in Specialized Patient Care Todd Raehtz, MBA, MSPA, BPharm - CEO and President, Indispensable Health | Conference Room IV |
| 2:30 PM – 3:10 PM | #702 – Ifeanyi Egbunike-ChukwumaCEBreakout Session #700: Pharmacy Practice - Transforming Health-System Pharmacy Practice: Access and Impact in Specialized Patient Care Ifeanyi Egbunike-Chukwuma, PharmD, BCPS - Director of Pharmacy Services, Luminis Health | Conference Room IV |
| 3:10 PM – 3:45 PM | #703 – Jessica AnglesonCEBreakout Session #700: Pharmacy Practice - Transforming Health-System Pharmacy Practice: Access and Impact in Specialized Patient Care Jessica Angleson, PharmD, MBA, BCPS - Managing Network Facilitator, CPESN Colorado | Conference Room IV |
| 3:45 PM – 4:00 PM | Moderated Discussion & Q&A (Session #700)Discussion Session #700: Pharmacy Practice - Transforming Health-System Pharmacy Practice: Access and Impact in Specialized Patient Care Panelists: Raehtz, Egbunike-Chukwuma, Angleson • Moderator: Felix Egbase, RPh (Aaron Pharmacy Inc., Las Vegas, NV) | Conference Room IV |
| 4:00 PM – 6:00 PM | NAPPSA 2026 Annual General Membership MeetingBusiness Meeting | TBD |
| 8:00 PM | Conference BanquetSocial | Aurora Ballroom |
Sunday, September 20, 2026
| Time | Session | Room |
|---|---|---|
| 7:00 AM – 8:00 AM | BreakfastMeal | TBD |
| 7:00 AM – 11:00 AM | RegistrationRegistration | Aurora Foyer |
| 8:00 AM – 8:40 AM | #801 – Kenneth IzuoraCEPlenary Session #800A: Developments in Clinical Therapeutics I Kenneth Izuora, MD, MBA, FACE - Professor & Director, Endocrinology Fellowship Program, University of Nevada Las Vegas • Moderator: Patrick Nwakama, PharmD, BCPS - Senior Pharmacologist, FDA | Aurora I/II |
| 8:40 AM – 9:25 AM | #802 – Jane E.B. ReuschCEPlenary Session #800A: Developments in Clinical Therapeutics I Jane E.B. Reusch, MD - Professor, University of Colorado School of Medicine • Moderator: Patrick Nwakama, PharmD, BCPS - Senior Pharmacologist, FDA | Aurora I/II |
| 9:25 AM – 10:05 AM | #803 – Meredith A. HawkinsCEPlenary Session #800A: Developments in Clinical Therapeutics I Meredith A. Hawkins, MD - Professor, Albert Einstein College of Medicine • Moderator: Patrick Nwakama, PharmD, BCPS - Senior Pharmacologist, FDA | Aurora I/II |
| 10:05 AM – 10:15 AM | BreakBreak | TBD |
| 10:15 AM – 10:45 AM | #804 – Nkem P. NonyelCEPlenary Session #800B: Developments in Clinical Therapeutics II Nkem P. Nonyel, PharmD, MPH, BCPS - Associate Professor, Howard University College of Pharmacy • Moderator: Nonye Nwaneri-Iwuchukwu, PharmD, BCOP (Harris Health, Houston, TX); Glory Uzunma Nosike, PharmD (Choice Pharmacy) | Aurora I/II |
| 10:45 AM – 11:15 AM | #805 – Charlotte WagnerCEPlenary Session #800B: Developments in Clinical Therapeutics II Charlotte Wagner, PharmD, BCOP - Assistant Professor, University of Colorado Skaggs School of Pharmacy • Moderator: Nonye Nwaneri-Iwuchukwu, PharmD, BCOP (Harris Health, Houston, TX); Glory Uzunma Nosike, PharmD (Choice Pharmacy) | Aurora I/II |
| 11:15 AM – 11:45 AM | Moderated Discussion & Q&A (Session #800B)Discussion Session #800B: Developments in Clinical Therapeutics II Panelists: Izuora, Reusch, Hawkins, Nonyel, Wagner • Moderator: Nonye Nwaneri-Iwuchukwu, PharmD, BCOP (Harris Health, Houston, TX); Glory Uzunma Nosike, PharmD (Choice Pharmacy) | Aurora I/II |
| 12:00 PM | Conference Conclusion and PicturesCeremony | TBD |
Continuing Education
Continuing Education
Maximum earnable: 17.0 contact hours (1.70 CEUs). Total offered across all activities: 18.0 hours. Provider: Practicing Pharmacists Institute (PPI), ACPE Provider #0691.
Maximum earnable: 17.0 contact hours (1.70 CEUs). Total offered across all activities: 18.0 hours. Provider: Practicing Pharmacists Institute (PPI), ACPE Provider #0691.
| UAN | Activity | Hours | Type |
|---|---|---|---|
| 0691-0000-26-200-L04-P | Session #100A: Bridging Pharmacy Education and Practice Innovation through Collaboration (Part 1) | 2.0 | Application |
| 0691-0000-26-201-L04-P | Session #100B: Bridging Pharmacy Education and Practice Innovation through Collaboration (Part 2) | 2.0 | Application |
| 0691-0000-26-202-L04-P | Session #200: Globalizing Innovations in Healthcare: Bridging Science, Access, and Impact | 2.5 | Application |
| 0691-0000-26-203-L04-P | Session #300: Drug Development and Manufacturing for Access: Innovations That Reduce Cost, Complexity, and Risk | 2.5 | Application |
| 0691-0000-26-204-L04-P | Session #400: Pharmacy Business Innovations: Models, Policy, and Technology for Access and Impact | 1.0 | Application |
| 0691-0000-26-205-L04-P | Session #500: YP Session – Building a Borderless Career in Pharmacy and Pharmaceutical Sciences | 1.0 | Application |
| 0691-0000-26-206-L04-P | Session #600: Keynote Presentation (Oluyinka Olutoye) | 1.0 | Application |
| 0691-0000-26-207-L04-P | Session #700: Transforming Health-System Pharmacy Practice: Access and Impact in Specialized Patient Care | 2.0 | Application |
| 0691-0000-26-208-L04-P | Session #800A: Developments in Clinical Therapeutics I | 2.0 | Knowledge |
| 0691-0000-26-209-L04-P | Session #800B: Developments in Clinical Therapeutics II | 2.0 | Knowledge |